Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

This notice describes an early-phase (Phase 1) trial evaluating a monoclonal antibody therapy for patients with recurrent acute lymphoblastic leukemia or non-Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Monoclonal antibody therapy

Snippet

Sponsor: Parker Hughes Cancer Center | Conditions: Leukemia, Lymphoma | Phase 1 | Status: UNKNOWN